Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 5
2009 6
2010 8
2011 12
2012 5
2013 3
2014 5
2015 4
2017 1
2018 3
2020 2
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: isose s. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Free PMC article. Clinical Trial.
Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis.
Sugimoto K, Mori M, Liu J, Shibuya K, Isose S, Koide M, Hiwasa T, Kuwabara S. Sugimoto K, et al. Among authors: isose s. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):388-394. doi: 10.1080/21678421.2021.1885448. Epub 2021 Apr 1. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 33792444
Cognitive and behavioral status in Japanese ALS patients: a multicenter study.
Watanabe Y, Raaphorst J, Izumi Y, Yoshino H, Ito S, Adachi T, Takigawa H, Masuda M, Atsuta N, Adachi Y, Isose S, Arai K, Yokota O, Oda M, Ogino M, Ichikawa H, Hasegawa K, Kimura H, Shimizu T, Aiba I, Yabe H, Kanba M, Kusumi K, Aoki T, Hiroe Y, Watanabe H, Nishiyama K, Nomoto M, Sobue G, Beeldman E, Hanajima R, Nakashima K; ALS-FTD-Q-J research group. Watanabe Y, et al. Among authors: isose s. J Neurol. 2020 May;267(5):1321-1330. doi: 10.1007/s00415-019-09655-9. Epub 2020 Jan 18. J Neurol. 2020. PMID: 31955246
Distal motor axonal dysfunction in amyotrophic lateral sclerosis.
Noto Y, Kanai K, Misawa S, Shibuya K, Isose S, Nasu S, Sekiguchi Y, Fujimaki Y, Nakagawa M, Kuwabara S. Noto Y, et al. Among authors: isose s. J Neurol Sci. 2011 Mar 15;302(1-2):58-62. doi: 10.1016/j.jns.2010.11.025. Epub 2010 Dec 31. J Neurol Sci. 2011. PMID: 21195434
49 results